Intermittent fasting regimens for metabolic dysfunction-associated steatotic liver disease: a systematic review and network meta-analysis of randomized controlled trials

aFaculty of Medicine, Tanta University, Tanta, Egypt

bDepartment of Internal Medicine, University of Missouri, Kansas, Missouri, USA

cFaculty of Medicine, Al-Azhar University, Asyut, Egypt

dFaculty of Medicine, University of Algiers, Algiers, Algeria

eFaculty of Medicine, Yarmouk University, Irbid, Jordan

fGeneral Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA

gFaculty of Medicine, Hashemite University, Zarqa, Jordan

hFaculty of Medicine, Jordan University of Science and Technology, Irbid, Jordan

iDepartment of Clinical Pharmacy, University of Michigan, Ann Arbor, Michigan, USA

jDepartment of Cardiology, West Virginia University, West Virginia, USA

Received 1 November 2023 Accepted 18 December 2023.

*Dr. Mohamed T. Abuelazm and Dr. Islam Mohamed contributed equally to the writing of this article and are considered as a co-first author.

Supplemental Digital Content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal’s website, www.eurojgh.com.

Correspondence to: Mohamed T. Abuelazm, MBBCh, Faculty of Medicine, Tanta Unversity, Tanta, Gharbia Governorate, Egypt Tel: +20 109 124 2822; e-mail: [email protected]; [email protected]

留言 (0)

沒有登入
gif